XML 10 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 44,931 $ 13,919 $ 94,851 $ 46,540
General and administrative 4,568 4,345 13,628 13,057
Total operating expenses 49,499 18,264 108,479 59,597
Loss from operations (49,499) (18,264) (108,479) (59,597)
Other income, net 1,787 2,765 5,304 7,817
Net loss $ (47,712) $ (15,499) $ (103,175) $ (51,780)
Net loss per share, basic $ (0.61) $ (0.24) $ (1.5) $ (0.86)
Net loss per share, diluted $ (0.61) $ (0.24) $ (1.5) $ (0.86)
Weighted average common shares outstanding, basic 78,324,767 63,806,158 68,824,826 60,399,697
Weighted average common shares outstanding, diluted 78,324,767 63,806,158 68,824,826 60,399,697
Comprehensive loss:        
Net Income (Loss) $ (47,712) $ (15,499) $ (103,175) $ (51,780)
Other comprehensive loss:        
Unrealized gain (loss) on marketable securities 75 508 (82) 277
Total other comprehensive gain (loss) 75 508 (82) 277
Total comprehensive loss $ (47,637) $ (14,991) $ (103,257) $ (51,503)